Stock BMRN BIOMARIN PHARMACEUTICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar BioMarin Pharmaceutical Inc.

Equities

BMRN

US09061G1013

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
80.91 USD -1.53% Intraday chart for BioMarin Pharmaceutical Inc. -8.71% -16.09%
04-25 Scotiabank Adjusts Price Target on BioMarin Pharmaceutical to $85 From $83, Maintains Sector Perform Rating MT
04-25 Wells Fargo Adjusts Price Target on BioMarin Pharmaceutical to $110 From $100, Maintains Overweight Rating MT

Chart calendar BioMarin Pharmaceutical Inc.

297df785e77953193.UAlSQDFNTcY8sbSHMHSbqP1ANQLOpPjsRr5ZxPzK6Y0.YE4hD18EG_ZviOzhUQTrmZcUAjL_45q8DecKp56Oq9cBPRExaQUginrE9Q~711878e8d4232146083781e3222af704

Upcoming events on BioMarin Pharmaceutical Inc.

21/05/2024 17:00 Annual General Meeting
29/07/2024 Q2 2024 Earnings Release (Projected)
22/10/2024 Q3 2024 Earnings Release (Projected)
19/02/2025 Q4 2024 Earnings Release (Projected)
22/04/2025 Q1 2025 Earnings Release (Projected)

Past events on BioMarin Pharmaceutical Inc.

24/04/2024 21:30 Q1 2024 Earnings Call
24/04/2024 21:03 Q1 2024 Earnings Release
15/03/2024 14:30 American College of Medical Genetics Meeting - Poster #: P144
15/03/2024 14:30 American College of Medical Genetics Meeting - Poster #: P034
14/03/2024 17:30 American College of Medical Genetics Meeting - Oral Session: O03
14/03/2024 14:30 American College of Medical Genetics Meeting - Poster #: P131
14/03/2024 14:30 American College of Medical Genetics Meeting - Poster #: P139
14/03/2024 14:30 American College of Medical Genetics Meeting - Poster #: P141
14/03/2024 14:30 American College of Medical Genetics Meeting - Poster #: P049
12/03/2024 17:35 Barclays Global Healthcare Conference - Fireside Chat
11/03/2024 Jefferies Biotech on the Bay Summit
11/03/2024 14:40 Leerink Partners Global Biopharma Conference - Fireside Chat
05/03/2024 17:50 TD Cowen Health Care Conference - Fireside Chat
22/02/2024 21:30 Q4 2023 Earnings Call
22/02/2024 21:03 Q4 2023 Earnings Release
09/02/2024 07:30 European Association for Haemophilia and Allied Disorders Congress - Oral No OR02
09/02/2024 07:30 European Association for Haemophilia and Allied Disorders Congress - Oral No OR10
09/02/2024 07:30 European Association for Haemophilia and Allied Disorders Congress - Oral No OR06
07/02/2024 17:30 European Association for Haemophilia and Allied Disorders Congress - Poster No PO314
07/02/2024 17:30 European Association for Haemophilia and Allied Disorders Congress - Poster No PO124

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		1 704
1 708
-0.22%		1 860
1 851
0.53%		1 846
1 843
0.2%		2 096
2 096
-0.02%		2 419
2 412
0.31%
2 740

EBITDA
Million USD		Released
Forecast
Spread 		4,84
1,92
151.64%		68,4
106
-35.65%		25,7
25,6
0.24%		252
234
7.3%		262
309
-14.96%
507

EBIT
Million USD		Released
Forecast
Spread 		-100
-100,0
-0.47%		-36,8
-17,7
-107.38%		-82,3
-76,7
-7.4%		150
158
-5.08%		158
197
-19.91%
449

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-94,8
-95,0
0.15%		-42,3
-26,1
-61.91%		-75,4
-75,1
-0.29%		150
150
-0.48%		189
230
-18.18%
462

Net income
Million USD		Released
Forecast
Spread 		-23,8
-53,0
55.01%		859
804
6.87%		-64,1
-67,7
5.3%		142
131
8.47%		168
190
-11.69%
358

EPS
USD		Released
Forecast
Spread 		-0,13
-0,29
55.03%		4,53
4,24
6.94%		-0,35
-0,37
5.12%		0,75
0,68
9.89%		0,87
0,98
-11.21%
1,81

Announcement Date26/02/2025/02/2123/02/2227/02/2322/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		519
509
1.97%		534
522
2.27%		505
516
-2.04%		538
538
-0.13%		596
570
4.56%		595
595
0.01%		581
608
-4.35%		646
637
1.46%		649
652
-0.46%
661


691


742


727


751

EBITDA
Million USD		Released
Forecast
Spread 		165
41,5
296.86%		64,4
55,8
15.49%		22,4
63,4
-64.72%		0,05
60,6
-99.91%		85,8
99,4
-13.71%


51,3


41,1
40,5
1.55%		116
90,7
27.64%
101


79,2


128







EBIT
Million USD		Released
Forecast
Spread 		137
45,1
204.31%		39,2
30,7
27.55%		-2,42
10,7
-122.55%		-24,5
-4,85
-405.07%		59,3
40,0
48.39%		58,9
56,3
4.56%		25,7
45,7
-43.88%		14,2
50,9
-72.04%		88,5
78,3
12.91%
78,5


108


133


141


154

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		134
65,5
104.78%		34,9
25,9
34.35%		-1,90
2,90
-165.68%		-17,6
-11,7
-49.75%		56,8
28,8
96.93%		70,8
42,3
67.56%		41,7
52,7
-20.99%		19,3
55,9
-65.45%		106
72,1
46.43%
93,8


117


139


143


153

Net income
Million USD		Released
Forecast
Spread 		121
56,5
113.91%		27,7
16,4
68.52%		-6,65
-0,74
-801.15%		-0,25
-12,2
97.95%		50,9
29,1
74.76%		56,0
42,5
31.76%		40,4
42,4
-4.73%		20,4
43,2
-52.79%		88,7
61,9
43.19%
73,1


93,4


110


109


119

EPS
USD		Released
Forecast
Spread 		0,63
0,24
157.44%		0,15
0,09
66.57%		-0,04
0,00
-1008.03%		0,00
-0,07
- 		0,27
0,15
76.85%		0,29
0,21
37.87%		0,21
0,22
-4.23%		0,11
0,22
-50.46%		0,46
0,33
40.75%
0,35


0,47


0,57


0,54


0,59

Announcement Date27/04/2203/08/2226/10/2227/02/2326/04/2331/07/2301/11/2322/02/2424/04/24-----

Upcoming sector events for BioMarin Pharmaceutical Inc.

28/04/2024 HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release
28/04/2024 CANSINO BIOLOGICS INC.: Q1 2024 Earnings Release
28/04/2024 SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release
28/04/2024 SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release (Projected)
29/04/2024 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: Q1 2024 Earnings Release
29/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release
29/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release
29/04/2024 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release
30/04/2024 12:00 INCYTE CORPORATION: Q1 2024 Earnings Release
More events

Past sector events for BioMarin Pharmaceutical Inc.

26/04/2024 PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q4 2023 Earnings Release
26/04/2024 BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.: Q1 2024 Earnings Release
26/04/2024 SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
26/04/2024 PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q1 2024 Earnings Release
26/04/2024 TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
25/04/2024 SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
25/04/2024 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 HUALAN BIOLOGICAL VACCINE INC.: Q1 2024 Earnings Release
25/04/2024 HUALAN BIOLOGICAL ENGINEERING INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BMRN Stock
  4. Calendar BioMarin Pharmaceutical Inc.